name,category,termsATG7 autophagy related 7 homolog (S. cerevisiae),INTERPRO[450000507$IPR000594:UBA/THIF-type NAD/FAD binding fold, 450005710$IPR006285:E1-like protein-activating enzyme Gsa7p/Apg7p, 450014426$IPR016040:NAD(P)-binding domain]
ATG7 autophagy related 7 homolog (S. cerevisiae),KEGG_PATHWAY[470038839$hsa04140:Regulation of autophagy]
ATG7 autophagy related 7 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000148$autophagy, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism, 790001266$protein transport, 790001558$transport, 790001593$ubl conjugation pathway]
ATG7 autophagy related 7 homolog (S. cerevisiae),UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850006890$chain:Autophagy-related protein 7, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
T-box 21,INTERPRO[450001505$IPR001699:Transcription factor, T-box, 450016474$IPR018186:Transcription factor, T-box, conserved site]
T-box 21,OMIM_DISEASE[520000408$Asthma and nasal polyps, 520000410$Asthma, aspirin-induced, susceptibility to]
T-box 21,SMART[760000371$SM00425:TBOX]
T-box 21,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
T-box 21,UP_SEQ_FEATURE[850063336$chain:T-box transcription factor TBX21, 850102955$DNA-binding region:T-box, 850117295$sequence variant]
adaptor-related protein complex 1, gamma 1 subunit,INTERPRO[450002270$IPR002553:Clathrin/coatomer adaptor, adaptin-like, N-terminal, 450007483$IPR008152:Clathrin adaptor, alpha/beta/gamma-adaptin, appendage, Ig-like subdomain, 450007484$IPR008153:Clathrin adaptor, gamma-adaptin, appendage, 450010814$IPR011989:Armadillo-like helical, 450015427$IPR017107:Adaptor protein complex AP-1, gamma subunit]
adaptor-related protein complex 1, gamma 1 subunit,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
adaptor-related protein complex 1, gamma 1 subunit,PIR_SUPERFAMILY[630028597$PIRSF037094:adaptor protein complex AP-1, gamma subunit, 630028598$PIRSF037094:AP1_complex_gamma]
adaptor-related protein complex 1, gamma 1 subunit,SMART[760000711$SM00809:Alpha_adaptinC2]
adaptor-related protein complex 1, gamma 1 subunit,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000496$Endocytosis, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
adaptor-related protein complex 1, gamma 1 subunit,UP_SEQ_FEATURE[850005699$chain:AP-1 complex subunit gamma-1, 850104033$domain:GAE, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
calcium channel, voltage-dependent, L type, alpha 1F subunit,INTERPRO[450001840$IPR002077:Voltage-dependent calcium channel, alpha-1 subunit, 450004905$IPR005446:Voltage-dependent calcium channel, L-type, alpha-1 subunit, 450005268$IPR005821:Ion transport, 450013322$IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain]
calcium channel, voltage-dependent, L type, alpha 1F subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038844$hsa04260:Cardiac muscle contraction, 470038845$hsa04270:Vascular smooth muscle contraction, 470038883$hsa04912:GnRH signaling pathway, 470038891$hsa05010:Alzheimer's disease, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy]
calcium channel, voltage-dependent, L type, alpha 1F subunit,OMIM_DISEASE[520000189$Aland Island eye disease, 520001161$Cone-rod dystrophy, X-linked, 3, 520003657$Night blindness, congenital stationary, X-linked, type 2, 520003658$Night blindness, congenital stationary, X-linked, type 2A, 520003738$Ocular albinism, Forsius-Eriksson type]
calcium channel, voltage-dependent, L type, alpha 1F subunit,PIR_SUPERFAMILY[630005588$PIRSF005657:voltage-gated calcium channel]
calcium channel, voltage-dependent, L type, alpha 1F subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000357$Cone-rod dystrophy, 790000366$Congenital stationary night blindness, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001377$sensory transduction, 790001555$transmembrane, 790001558$transport, 790001622$vision, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, L type, alpha 1F subunit,UP_SEQ_FEATURE[850100534$chain:Voltage-dependent L-type calcium channel subunit alpha-1F, 850102572$compositionally biased region:Poly-Glu, 850102575$compositionally biased region:Poly-Ile, 850102576$compositionally biased region:Poly-Leu, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850111061$region of interest:Binding to the beta subunit, 850111436$region of interest:Dihydropyridine binding, 850114003$region of interest:Phenylalkylamine binding, 850116205$repeat:I, 850116211$repeat:II, 850116226$repeat:III, 850116236$repeat:IV, 850117294$sequence conflict, 850117295$sequence variant, 850117960$site:Calcium ion selectivity and permeability, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
calicin,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450002096$IPR002355:Multicopper oxidase, copper-binding site, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller]
calicin,SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
calicin,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000428$developmental protein, 790000434$differentiation, 790000819$kelch repeat, 790001212$polymorphism, 790001304$repeat, 790001426$spermatogenesis]
calicin,UP_SEQ_FEATURE[850009107$chain:Calicin, 850103083$domain:BACK, 850103177$domain:BTB, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6, 850117294$sequence conflict, 850117295$sequence variant]
casein kinase 1, alpha 1,BIOCARTA[30000199$h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart), 30000214$h_p35alzheimersPathway:Deregulation of CDK5 in Alzheimers Disease, 30000216$h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system, 30000313$h_wntPathway:WNT Signaling Pathway]
casein kinase 1, alpha 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
casein kinase 1, alpha 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038849$hsa04340:Hedgehog signaling pathway]
casein kinase 1, alpha 1,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein, 630031202$PIRSF501113:casein kinase 1]
casein kinase 1, alpha 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000825$kinase, 790000827$kinetochore, 790000973$mitosis, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase, 790001642$wnt signaling pathway]
casein kinase 1, alpha 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009774$chain:Casein kinase I isoform alpha, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 20 open reading frame 196,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 20 open reading frame 196,UP_SEQ_FEATURE[850073719$chain:Uncharacterized protein C20orf196, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 40, member B,INTERPRO[450011166$IPR012486:N1221-like]
family with sequence similarity 40, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 40, member B,UP_SEQ_FEATURE[850045982$chain:Protein FAM40B, 850102576$compositionally biased region:Poly-Leu, 850117295$sequence variant, 850118574$splice variant]
interleukin 17B,INTERPRO[450009410$IPR010345:Interleukin-17]
interleukin 17B,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction]
interleukin 17B,PIR_SUPERFAMILY[630003490$PIRSF003430:interleukin-17, 630031173$PIRSF501047:interleukin-17B]
interleukin 17B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
interleukin 17B,UP_SEQ_FEATURE[850026541$chain:Interleukin-17B, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide]
lipocalin 10,INTERPRO[450002086$IPR002345:Lipocalin, 450011355$IPR012674:Calycin]
lipocalin 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal, 790001558$transport]
lipocalin 10,UP_SEQ_FEATURE[850017664$chain:Epididymal-specific lipocalin-10, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide]
low density lipoprotein receptor class A domain containing 1,INTERPRO[450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich]
low density lipoprotein receptor class A domain containing 1,SMART[760000166$SM00192:LDLa]
low density lipoprotein receptor class A domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000881$lipoprotein, 790000919$membrane, 790001301$receptor, 790001304$repeat, 790001555$transmembrane]
low density lipoprotein receptor class A domain containing 1,UP_SEQ_FEATURE[850029117$chain:Low-density lipoprotein receptor class A domain-containing protein 1, 850102883$disulfide bond, 850104665$domain:LDL-receptor class A 1, 850104689$domain:LDL-receptor class A 2; atypical, 850104699$domain:LDL-receptor class A 3; atypical, 850118574$splice variant, 850118623$transmembrane region]
misato homolog 1 (Drosophila),INTERPRO[450002643$IPR003008:Tubulin/FtsZ, GTPase domain, 450017842$IPR019605:Misato Segment II, myosin-like]
misato homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001162$phosphoprotein, 790001212$polymorphism]
misato homolog 1 (Drosophila),UP_SEQ_FEATURE[850046888$chain:Protein misato homolog 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
neural precursor cell expressed, developmentally down-regulated 9,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450013377$IPR014928:Serine rich protein interaction]
neural precursor cell expressed, developmentally down-regulated 9,SMART[760000295$SM00326:SH3]
neural precursor cell expressed, developmentally down-regulated 9,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000258$cell cycle, 790000260$cell division, 790000263$cell junction, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000624$golgi apparatus, 790000635$growth regulation, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
neural precursor cell expressed, developmentally down-regulated 9,UP_SEQ_FEATURE[850017457$chain:Enhancer of filamentation 1, 850017458$chain:Enhancer of filamentation 1 p55, 850105350$domain:SH3, 850106258$modified residue, 850111448$region of interest:Divergent helix-loop-helix motif, 850113083$region of interest:Interacts strongly with spindle- regulatory protein D1M1, 850117295$sequence variant, 850117333$short sequence motif:Caspase cleavage related site]
nibrin,BIOCARTA[30000028$h_atmPathway:ATM Signaling Pathway, 30000029$h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility]
nibrin,INTERPRO[450000219$IPR000253:Forkhead-associated, 450001201$IPR001357:BRCT, 450012504$IPR013908:DNA  repair Nbs1, C-terminal, 450014914$IPR016592:Nibrin]
nibrin,KEGG_PATHWAY[470038825$hsa03440:Homologous recombination]
nibrin,OMIM_DISEASE[520002832$Leukemia, acute lymphoblastic, 520003660$Nijmegen breakage syndrome]
nibrin,PIR_SUPERFAMILY[630010115$PIRSF011869:nibrin, animal type, 630010116$PIRSF011869:Nibrin_animal]
nibrin,SMART[760000212$SM00240:FHA, 760000263$SM00292:BRCT]
nibrin,SP_PIR_KEYWORDS[790000258$cell cycle, 790000315$chromosomal protein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000452$DNA damage, 790000459$dna repair, 790000915$meiosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001494$telomere]
nibrin,UP_SEQ_FEATURE[850034231$chain:Nibrin, 850102570$compositionally biased region:Poly-Gln, 850103153$domain:BRCT, 850103775$domain:FHA, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117439$short sequence motif:EEXXXDDL motif, 850117610$short sequence motif:Nuclear localization signal]
phosphate cytidylyltransferase 1, choline, alpha,INTERPRO[450004304$IPR004820:Cytidylyltransferase, 450004305$IPR004821:Cytidyltransferase-related, 450013180$IPR014729:Rossmann-like alpha/beta/alpha sandwich fold]
phosphate cytidylyltransferase 1, choline, alpha,KEGG_PATHWAY[470038778$hsa00564:Glycerophospholipid metabolism]
phosphate cytidylyltransferase 1, choline, alpha,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000447$disulfide bond, 790000919$membrane, 790001064$nucleotidyltransferase, 790001156$phospholipid biosynthesis, 790001162$phosphoprotein, 790001304$repeat, 790001547$transferase]
phosphate cytidylyltransferase 1, choline, alpha,UP_SEQ_FEATURE[850011220$chain:Choline-phosphate cytidylyltransferase A, 850102883$disulfide bond, 850106258$modified residue, 850110189$region of interest:3 X 11 AA approximate tandem repeats, 850110288$region of interest:3 X repeats, 850110924$region of interest:Amphipathic, 850111190$region of interest:Catalytic, 850115074$repeat:1, 850115413$repeat:2; approximate, 850115417$repeat:3, 850117294$sequence conflict]
platelet factor 4,INTERPRO[450000954$IPR001089:Small chemokine, C-X-C, 450001604$IPR001811:Small chemokine, interleukin-8-like, 450002193$IPR002473:Small chemokine, C-X-C/Interleukin 8, 450016352$IPR018048:Small chemokine, C-X-C, conserved site]
platelet factor 4,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
platelet factor 4,PIR_SUPERFAMILY[630002641$PIRSF002522:CXC chemokine, 630030763$PIRSF500566:platelet factor 4]
platelet factor 4,SMART[760000172$SM00199:SCY]
platelet factor 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000192$blood coagulation, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000668$heparin binding, 790000669$heparin-binding, 790000706$homotetramer, 790001205$platelet, 790001363$Secreted, 790001405$signal]
platelet factor 4,UP_SEQ_FEATURE[850039514$chain:Platelet factor 4, 850039519$chain:Platelet factor 4, short form, 850102883$disulfide bond, 850105852$helix, 850117294$sequence conflict, 850117814$signal peptide, 850118575$strand]
postmeiotic segregation increased 2-like 3; zinc finger protein 12,COG_ONTOLOGY[90000073$General function prediction only]
postmeiotic segregation increased 2-like 3; zinc finger protein 12,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450001859$IPR002099:DNA mismatch repair protein, 450003155$IPR003594:ATP-binding region, ATPase-like, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450013876$IPR015434:Post Meiotic Segregation 2, 450014303$IPR015880:Zinc finger, C2H2-like]
postmeiotic segregation increased 2-like 3; zinc finger protein 12,PIR_SUPERFAMILY[630005483$PIRSF005559:zinc finger protein ZFP-36]
postmeiotic segregation increased 2-like 3; zinc finger protein 12,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2, 760000339$SM00387:HATPase_c]
postmeiotic segregation increased 2-like 3; zinc finger protein 12,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000459$dna repair, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
postmeiotic segregation increased 2-like 3; zinc finger protein 12,UP_SEQ_FEATURE[850040030$chain:Postmeiotic segregation increased 2-like protein 3, 850101440$chain:Zinc finger protein 12, 850104552$domain:KRAB, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8]
protocadherin 24,INTERPRO[450001884$IPR002126:Cadherin]
protocadherin 24,SMART[760000099$SM00112:CA]
protocadherin 24,SP_PIR_KEYWORDS[790000211$calcium, 790000256$cell adhesion, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
protocadherin 24,UP_SEQ_FEATURE[850048759$chain:Protocadherin-24, 850103211$domain:Cadherin 1, 850103222$domain:Cadherin 2, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850103242$domain:Cadherin 7, 850103243$domain:Cadherin 8, 850103244$domain:Cadherin 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
sialic acid binding Ig-like lectin 10,INTERPRO[450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450011799$IPR013162:CD80-like, immunoglobulin C2-set]
sialic acid binding Ig-like lectin 10,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
sialic acid binding Ig-like lectin 10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
sialic acid binding Ig-like lectin 10,UP_SEQ_FEATURE[850000550$binding site:Sialic acid, 850060683$chain:Sialic acid-binding Ig-like lectin 10, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
similar to CG10103; KIAA0174,INTERPRO[450004530$IPR005061:Protein of unknown function DUF292, eukaryotic]
similar to CG10103; KIAA0174,OMIM_DISEASE[520001144$Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study]
similar to CG10103; KIAA0174,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790001162$phosphoprotein]
similar to CG10103; KIAA0174,UP_SEQ_FEATURE[850026925$chain:IST1 homolog, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112188$region of interest:Interaction with CHMP1A and CHMP1B, 850113022$region of interest:Interaction with VPS37B, 850113026$region of interest:Interaction with VPS4A, VTA1, MITD1 STAMBP and USP8, 850113035$region of interest:Interaction with VTA1, 850117580$short sequence motif:MIT-interacting motif, 850117752$short sequence motif:Type-2 MIT-interacting motif, 850118574$splice variant, 850118624$turn]
small nuclear ribonucleoprotein 27kDa (U4/U6.U5),INTERPRO[450012551$IPR013957:Protein of unknown function DUF1777]
small nuclear ribonucleoprotein 27kDa (U4/U6.U5),KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
small nuclear ribonucleoprotein 27kDa (U4/U6.U5),SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
small nuclear ribonucleoprotein 27kDa (U4/U6.U5),UP_SEQ_FEATURE[850067864$chain:U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein, 850102404$compositionally biased region:Arg-rich, 850106258$modified residue, 850117295$sequence variant]
spermatogenesis associated 20,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
spermatogenesis associated 20,INTERPRO[450004353$IPR004879:Protein of unknown function DUF255, 450011036$IPR012335:Thioredoxin fold]
spermatogenesis associated 20,PIR_SUPERFAMILY[630006343$PIRSF006402:uncharacterized protein with thioredoxin domain]
spermatogenesis associated 20,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001212$polymorphism, 790001405$signal, 790001426$spermatogenesis]
spermatogenesis associated 20,UP_SEQ_FEATURE[850061885$chain:Spermatogenesis-associated protein 20, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
synaptic vesicle glycoprotein 2B; hypothetical protein LOC100128403,INTERPRO[450005276$IPR005829:Sugar transporter, conserved site, 450005432$IPR005988:Synaptic vesicle protein SV2, 450010529$IPR011701:Major facilitator superfamily MFS-1]
synaptic vesicle glycoprotein 2B; hypothetical protein LOC100128403,KEGG_PATHWAY[470038854$hsa04512:ECM-receptor interaction]
synaptic vesicle glycoprotein 2B; hypothetical protein LOC100128403,OMIM_DISEASE[520001989$Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum]
synaptic vesicle glycoprotein 2B; hypothetical protein LOC100128403,PIR_SUPERFAMILY[630002897$PIRSF002806:synaptic vesicle protein SV2]
synaptic vesicle glycoprotein 2B; hypothetical protein LOC100128403,SP_PIR_KEYWORDS[790000263$cell junction, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000616$glycoprotein, 790000919$membrane, 790001027$neurotransmitter transport, 790001162$phosphoprotein, 790001475$synapse, 790001555$transmembrane, 790001558$transport]
synaptic vesicle glycoprotein 2B; hypothetical protein LOC100128403,UP_SEQ_FEATURE[850063158$chain:Synaptic vesicle glycoprotein 2B, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
transcription factor 7-like 1 (T-cell specific, HMG-box),INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2, 450012182$IPR013558:CTNNB1 binding, N-teminal]
transcription factor 7-like 1 (T-cell specific, HMG-box),KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038856$hsa04520:Adherens junction, 470038885$hsa04916:Melanogenesis, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038903$hsa05213:Endometrial cancer, 470038905$hsa05215:Prostate cancer, 470038906$hsa05216:Thyroid cancer, 470038907$hsa05217:Basal cell carcinoma, 470038911$hsa05221:Acute myeloid leukemia, 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC)]
transcription factor 7-like 1 (T-cell specific, HMG-box),SMART[760000349$SM00398:HMG]
transcription factor 7-like 1 (T-cell specific, HMG-box),SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation, 790001642$wnt signaling pathway]
transcription factor 7-like 1 (T-cell specific, HMG-box),UP_SEQ_FEATURE[850064989$chain:Transcription factor 7-like 1, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850102920$DNA-binding region:HMG box, 850111365$region of interest:CTNNB1-binding, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal]
tuberous sclerosis 1,BIOCARTA[30000195$h_mTORPathway:mTOR Signaling Pathway]
tuberous sclerosis 1,INTERPRO[450006837$IPR007483:Hamartin]
tuberous sclerosis 1,KEGG_PATHWAY[470038842$hsa04150:mTOR signaling pathway, 470038882$hsa04910:Insulin signaling pathway]
tuberous sclerosis 1,OMIM_DISEASE[520001918$Focal cortical dysplasia, Taylor balloon cell type, 520002976$Lymphangioleiomyomatosis, 520004934$Tuberous sclerosis-1]
tuberous sclerosis 1,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000509$epilepsy, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001580$tumor suppressor]
tuberous sclerosis 1,UP_SEQ_FEATURE[850022940$chain:Hamartin, 850102573$compositionally biased region:Poly-Gly, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117295$sequence variant]
tyrosylprotein sulfotransferase 1,PIR_SUPERFAMILY[630009541$PIRSF010916:Caenorhabditis elegans hypothetical protein F42G9.8]
tyrosylprotein sulfotransferase 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
tyrosylprotein sulfotransferase 1,UP_SEQ_FEATURE[850048631$chain:Protein-tyrosine sulfotransferase 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
ubiquitin-conjugating enzyme E2F (putative),INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
ubiquitin-conjugating enzyme E2F (putative),KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
ubiquitin-conjugating enzyme E2F (putative),PIR_SUPERFAMILY[630001737$PIRSF001566:NEDD8-conjugating enzyme]
ubiquitin-conjugating enzyme E2F (putative),SMART[760000185$SM00212:UBCc]
ubiquitin-conjugating enzyme E2F (putative),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000859$ligase, 790001063$nucleotide-binding, 790001593$ubl conjugation pathway]
ubiquitin-conjugating enzyme E2F (putative),UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850033809$chain:NEDD8-conjugating enzyme UBE2F, 850105852$helix, 850106258$modified residue, 850112987$region of interest:Interaction with UBA3, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
